Alira Health Joins France Biotech as an Expert Partner
Alira Health to Contribute Knowledge and Experience to French Companies
We are pleased to announce that Alira Health has joined France Biotech, an independent association that brings together healthcare innovation entrepreneurs and their expert partners.
As a stakeholder in France’s biotech ecosystem, Alira Health helps French companies progress in their long and challenging journey from research to providing value to patients. It also provides a wide variety of expertise – in clinical trials, patient engagement, transactions, market access, commercialization, and more – and links that expertise together under one roof to help biotech companies throughout their lifecycle management.
As expert partner in France Biotech, Alira Health is able to anticipate potential changes in the environment, such as regulatory, market fundamentals, and pricing, for France Biotech member companies who know their environment today but might be concerned about how to predict the future over the course of a possible ten-year journey to market.
“We’re happy to be a part of an association that gathers many French stakeholders in biotech, and look forward to providing members of France Biotech with our expertise,” says Joris Pezzini, Executive Vice President, Biopharma, Alira Health.
“We are delighted to welcome Alira Health among France Biotech new members! Their expertise is invaluable for the French health innovation ecosystem and the international dimension is a precious asset that will support the work of our association,” comments Olivier Chabanon, Director General, France Biotech.